Vanguard Group’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Buy |
2,725,240
+20,217
| +0.7% | +$119K | ﹤0.01% | 2658 |
|
|
2025
Q1 | $22.7M | Sell |
2,705,023
-27,562
| -1% | -$231K | ﹤0.01% | 2451 |
|
|
2024
Q4 | $20.3M | Sell |
2,732,585
-8,903
| -0.3% | -$66.2K | ﹤0.01% | 2575 |
|
|
2024
Q3 | $15.9M | Sell |
2,741,488
-883,406
| -24% | -$5.12M | ﹤0.01% | 2715 |
|
|
2024
Q2 | $24.1M | Sell |
3,624,894
-678,505
| -16% | -$4.51M | ﹤0.01% | 2473 |
|
|
2024
Q1 | $56.2M | Buy |
4,303,399
+9,610
| +0.2% | +$125K | ﹤0.01% | 2119 |
|
|
2023
Q4 | $54.7M | Buy |
4,293,789
+104,207
| +2% | +$1.33M | ﹤0.01% | 2152 |
|
|
2023
Q3 | $54.9M | Buy |
4,189,582
+155,835
| +4% | +$2.04M | ﹤0.01% | 2085 |
|
|
2023
Q2 | $103M | Buy |
4,033,747
+183,702
| +5% | +$4.7M | ﹤0.01% | 1832 |
|
|
2023
Q1 | $97M | Buy |
3,850,045
+573,196
| +17% | +$14.4M | ﹤0.01% | 1848 |
|
|
2022
Q4 | $75.3M | Buy |
3,276,849
+57,847
| +2% | +$1.33M | ﹤0.01% | 1958 |
|
|
2022
Q3 | $71M | Buy |
3,219,002
+284,961
| +10% | +$6.29M | ﹤0.01% | 2002 |
|
|
2022
Q2 | $42.1M | Buy |
2,934,041
+563,659
| +24% | +$8.08M | ﹤0.01% | 2274 |
|
|
2022
Q1 | $44.8M | Buy |
2,370,382
+94,603
| +4% | +$1.79M | ﹤0.01% | 2364 |
|
|
2021
Q4 | $42.4M | Buy |
2,275,779
+734,203
| +48% | +$13.7M | ﹤0.01% | 2451 |
|
|
2021
Q3 | $41.5M | Buy |
1,541,576
+585,416
| +61% | +$15.7M | ﹤0.01% | 2460 |
|
|
2021
Q2 | $29.9M | Buy |
+956,160
| New | +$29.9M | ﹤0.01% | 2633 |
|